Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques

Nature Methods

Volumn 12, Issue 5, 2015, Pages 427-432

  Santangelo, Philip J ^a   Rogers, Kenneth A ^b   Zurla, Chiara ^a   Blanchard, Emeline L ^a   Gumber, Sanjeev ^b,c   Strait, Karen ^b   Connor Stroud, Fawn ^b   Schuster, David M ^c   Amancha, Praveen K ^b   Hong, Jung Joo ^b   Byrareddy, Siddappa N ^c   Hoxie, James A ^d   Vidakovic, Brani ^a   Ansari, Aftab A ^c   Hunter, Eric ^c   Villinger, Francois ^b,c  

^a Emory University   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COPPER 64; GLYCOPROTEIN GP 120; MACROGOL; ADENINE; COPPER; DEOXYCYTIDINE; EMTRICITABINE; GP120 PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; L870812; MEMBRANE PROTEIN; NAPHTHYRIDINE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR; VIRUS ENVELOPE PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANTIVIRAL THERAPY; ARTICLE; COLON; CONTROLLED STUDY; GASTROINTESTINAL TRACT; GENITAL SYSTEM; IN VIVO STUDY; LUNG; LYMPH NODE; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIGNAL DETECTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SMALL INTESTINE; TURBINATE; VIREMIA; VIRUS DETECTION; VIRUS REPLICATION; WHOLE BODY PET; ANALOGS AND DERIVATIVES; ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

ADENINE; ANIMALS; ANTI-RETROVIRAL AGENTS; COPPER RADIOISOTOPES; DEOXYCYTIDINE; EMTRICITABINE; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; NAPHTHYRIDINES; ORGANOPHOSPHONATES; POSITRON-EMISSION TOMOGRAPHY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIMIAN IMMUNODEFICIENCY VIRUS; TENOFOVIR; VIRAL ENVELOPE PROTEINS; VIREMIA; VIRUS REPLICATION; WHOLE BODY IMAGING;

EID: 84928880432     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.3320     Document Type: Article

References (40)

1. Saéz-Cirión, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013).
2. Zaunders, J. & van Bockel, D. Innate and adaptive immunity in long-term non-progression in HIV disease. Front Immunol. 4, 95 (2013).
3. Gray, L. et al. Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source. Virol. J. 4, 75 (2007).
4. Visco-Comandini, U., Aleman, S., Yun, Z. & Sönnerborg, A. Human immunodeficiency virus type 1 variability and long-term non-progression. J. Biol. Regul. Homeost. Agents 15, 299-303 (2001).
5. Laird, G.M. et al. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog. 9, e1003398 (2013).
6. Di Mascio, M. et al. Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates. Blood 114, 328-337 (2009).
7. Dadachova, E. et al. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med. 3, e427 (2006).
8. Boerman, O.C. & Oyen, W.J. Immuno-PET of cancer: a revival of antibody imaging. J. Nucl. Med. 52, 1171-1172 (2011).
9. Fortin, M.A. et al. Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies. Eur. J. Nucl. Med. Mol. Imaging 34, 1376-1387 (2007).
10. Lucignani, G. et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur. J. Nucl. Med. Mol. Imaging 36, 640-647 (2009).
11. Brenchley, J.M. & Paiardini, M. Immunodeficiency lentiviral infections in natural and non-natural hosts. Blood 118, 847-854 (2011).
12. Lackner, A.A. & Veazey, R.S. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu. Rev. Med. 58, 461-476 (2007).
13. Edinger, A.L. et al. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J. Virol. 74, 7922-7935 (2000).
14. White, T.A. et al. Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J. Virol. 85, 12114-12123 (2011).
15. White, T.A. et al. Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog. 6, e1001249 (2010).
16. Wattendorf, U. & Merkle, H.P. PEGylation as a tool for the biomedical engineering of surface modified microparticles. J. Pharm. Sci. 97, 4655-4669 (2008).
17. Mortimer, J.E. et al. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using 64Cu-DOTA-trastuzumab PET. J. Nucl. Med. 55, 23-29 (2014).
18. Tamura, K. et al. 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer. J. Nucl. Med. 54, 1869-1875 (2013).
19. Picker, L.J. Immunopathogenesis of acute AIDS virus infection. Curr. Opin. Immunol. 18, 399-405 (2006).
20. Heise, C., Vogel, P., Miller, C.J., Halsted, C.H. & Dandekar, S. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am. J. Pathol. 142, 1759-1771 (1993).
21. Veazey, R.S. et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998).
22. Barber, S.A. et al. Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: compartmentalized regulation of SIV. J. Infect. Dis. 194, 931-938 (2006).
23. Le Tortorec, A. & Dejucq-Rainsford, N. HIV infection of the male genital tract-consequences for sexual transmission and reproduction. Int. J. Androl. 33, e98-e108 (2010).
24. Le Tortorec, A. et al. Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology 5, 119 (2008).
25. Shehu-Xhilaga, M. et al. The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection. Retrovirology 4, 7 (2007).
26. Miller, C.J. Localization of simian immunodeficiency virus-infected cells in the genital tract of male and female rhesus macaques. J. Reprod. Immunol. 41, 331-339 (1998).
27. Chacko, A.M. et al. Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide. Expert Opin. Drug Deliv. 10, 907-926 (2013).
28. Barton, K.M., Burch, B.D., Soriano-Sarabia, N. & Margolis, D.M. Prospects for treatment of latent HIV. Clin. Pharmacol. Ther. 93, 46-56 (2013).
29. Chun, T.W. & Fauci, A.S. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS 26, 1261-1268 (2012).
30. Hill, A. Optimizing HIV treatment. Curr. Opin. HIV AIDS 8, 34-40 (2013).
31. Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811-817 (2010).
32. Andrieux-Meyer, I. et al. Preferred antiretroviral drugs for the next decade of scale up. J. Int. AIDS Soc. 15, 17986 (2012).
33. Haase, A.T. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu. Rev. Med. 62, 127-139 (2011).
34. Lairmore, M.D., Post, A.A., Goldsmith, C.S. & Folks, T.M. Cytokine enhancement of simian immunodeficiency virus (SIV/mac) from a chronically infected cloned T-cell line (HuT-78). Arch. Virol. 121, 43-53 (1991).
35. Daniel, M.D. et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1201-1204 (1985).
36. Hong, J.J., Amancha, P.K., Rogers, K., Ansari, A.A. & Villinger, F. Spatial alterations between CD4+ T follicular helper, B, and CD8+ T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J. Immunol. 188, 3247-3256 (2012).
37. Hong, J.J., Amancha, P.K., Rogers, K., Ansari, A.A. & Villinger, F. Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection. PLoS ONE 8, e60186 (2013).
38. Torriani, M. et al. Increased FDG uptake in association with reduced extremity fat in HIV patients. Antivir. Ther. 18, 243-248 (2013).
39. Yant, L.J. et al. The high-frequency major histocompatibility complex class I allele Mamu-B∗17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80, 5074-5077 (2006).
40. Haralick, R.M., Shanmugam, K. & Dinstein, I. Textural features for image classification. IEEE Trans. Syst. Man Cybern. 3, 610-621 (1973).